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Activation of Bone Marrow Phagocytes
Following Benzene Treatment of Mice
by Debra L. Laskin,* Laureen MacEachern,* and
Robert Snyder*
Techniques inflowcytometry/cell sorting were usedtocharacterize the effects ofbenzene and its metabolites
on subpopulations ofbone marrow cells. Treatment ofmale Balb/c mice with benzene (880 mg/kg) or a com-
bination of its metabolites, hydroquinone and phenol (50 mg/kg), resulted in a 30 to 40% decrease in bone
marrow cellularity. Flow cytometric analysis revealed two supopulations ofbone marrow cells that could
be distinquished by their size and density or granularity. The larger, more dense subpopulation was found
to consistpredominantly ofmacrophages and granulocytes as determined by monoclonal antibody binding
and by cell sorting. Benzene treatment had no selective cytotoxic effects on subpopulations of bone mar-
row cells. To determine ifbenzene treatment activated bone marrow phagocytes, we quantified production
ofhydrogen peroxide by these cells using the fluorescent indicator dye, 2',7'-dichlorofluorescin diacetate.
We found thatmacrophages and granulocytes from bone marrow oftreated mice produced50%o more hydrogen
peroxide in response to the phorbol ester, 12-O-tetradecanoyl-phorbol-13-acetate than did cells from control
animals. It is hypothesized that phagocyte activation and production ofcytotoxic reactive oxygen intermedi-
ates may contribute to hematotoxicity induced by benzene.
Introduction
Benzene is a potent bone marrow toxin. Acute treat-
ment of experimental animals with benzene or its
metabolites results in a decrease in bone marrow cellular-
ity, as well as in impairedhematopoiesis and immune sys-
tem functioning(1-7). The mechanisms underlying these
effects are unknown, but may involve a direct action of
benzene orits metabolites on specific cellular components
of the bone marrow.
Recently, it has been proposed that bone marrow
stromal cells, inparticular, macrophages, may represent
aprimary cellular target for benzene (8-11). These cells
are known to release a variety ofcytokines and growth
factors that modulate the proliferation and activation of
stem cells (12,13). Following tissue injury or antigenic
stimulation, bone marrow macrophages, like other
mononuclear phagocytes, become activated. These cells
display enhanced functional and biochemical responsive-
ness and release elevated levels of cytokines (14). Acti-
vatedphagocytes alsoproduce highly reactive andpoten-
tially toxic oxygen intermediates including superoxide
anion, hydrogen peroxide, and hydroxyl radical (14-17).
Activation ofstromal phagocytes in the bone marrow fol-
lowing benzene exposure with associated alterations in
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the release ofgrowth regulatory molecules and/or reac-
tive oxygen intermediates may haveprofound effects on
stem cell proliferation and differentiation.
The present studies were designed to determine ifben-
zene treatment of mice activates bone marrow phago-
cytes to produce elevatedlevels ofreactive oxygen inter-
mediates. For these studies, we used techniques in flow
cytometry/cell sorting. The advantage ofthistechnology
is that itpermits rapid and precise analysis ofcellular ac-
tivation on a single cell basis from a mixedpopulation of
bone marrow cells. We found that benzene treatment of
mice depleted the number of recoverable bone marrow
cells. Accompanying this response, the toxin was found
to cause specific activation ofbone marrowmacrophages
and granulocytes. Thus, these cells produced elevated
levels of hydrogen peroxide. These results support the
hypothesis that benzene induced phagocyte activation
and production of cytotoxic reactive oxygen intermedi-
ates may contribute to hematotoxicity.
Materials and Methods
Treatment of Mice
Male Balb/cmice(Taconic Farms), 20to30g, wereused
in all experiments. Animals were injected SC with 880
mg/kgbenzene or a combination of50mg/kg phenol and
hydroquinone once per day for 3 days. Control animals
received corn oil or phosphate-buffered saline (PBS).LASKIN, MACEACHERN, AND SNYDER
Isolation of Bone Marrow Phagocytes
Control andtreated animals were killedby cervical dis-
location 24 hr afterthe lastinjection. The lowerlegbones
were then removed from the animals, and the femur and
tiba were flushed with 5 mL ofHank's balanced salt so-
lution (HBSS) to isolate bone marrow cells. Cell suspen-
sions were then washed twice with HBSS and con-
taminating red blood cells lysedusing0.75% ammonium
chloride in 20 mM Tris-HCl buffer (pH 7.2). Cells were
enumerated using a Coulter counter.
Indirect Immunofluorescence
To identify subpopulations of bone marrow cells, we
used the highly specific monoclonal antibody, Mac-1
(Hybritech), which binds to mouse macrophages, mono-
cytes, and granulocytes. Bone marrow cells (1 x 106)
were incubated with a 1:100 dilution ofMac-1 antibody at
40C. After 30 min, the cells were washed three times
with PBS containing 0.1% gelatin and incubated for an
additional 30 min at40C with fluorescein isothiocyanate
(FITC)-conjugated goat-F(ab')2 anti-rat IgG (Jackson
Labs). The percentage ofpositive cells bindingthe Mac-1
antibody was then determined by quantifying cell-
associated fluorescence at 515 to 550 nmusing a Coulter
Epics 753 dye laser flow cytometer/cell sorter equipped
with two 5-watt argon lasers. For each analysis, 20,000
events were recorded.
Measurement of Phagocyte Oxidative
Metabolism
Hydrogen peroxide productionbybone marrowphago-
cytes was monitored using the indicator dye,
2',7'-dichlorofluorescein diacetate (DCFH-DA, Molecular
Probes, Inc.) aspreviously described(15-18). DCFH-DA
is rapidly taken up by cells and cleaved by intracellular
esterases to yield the nonfluorescent compound, DCFH.
Hydrogen peroxide produced by activated phagocytes
hydrolyzes DCFH to the fluorescent compound,
2',7'-dichlorofluorescein (DCF). Thus, theintensity ofcell-
associated DCF fluorescence is directly proportional to
the amount ofhydrogen peroxide produced by the cells.
Bone marrow cells (1 x 106) were incubated for 15 min
at 370C with DCFH-DA followed by incubation with
12-O-tetradecanoylphorbol-13-acetate (TPA) orcontrol for
20 min. Green fluorescence associated with hydrogen
peroxide production was then detected at 515 to 550 nm
on the flow cytometer. Eachexperiment was repeated at
least three times with similar results.
Results
Effects of Benzene Treatment on Bone
Marrow Cellularity
Treatment of mice with benzene or a combination of
hydroquinone andphenol resultedin a30to 40% decrease
in the number ofcells recovered from the bone marrow.
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FIGURE 1. Effects ofbenzene and hydroquinone-phenol treatment of
mice on bone marrow cellularity. Mice were injected with benzene
(880 mg/kg), a combination ofhydroquinone and phenol (50 mg/kg)
orcontrol(corn oil orPBS)onceperdayfor3 days. Cellswerethen
isolatedfromthelowerlegbones, washed, andcounted. Eachbarrep-
resents the mean ± SE from3to 4 animals. Statistically significant
(p s 0.05) differencesbetween controlandtreatedanimals are shown
by asterisks (*) (Student's t-test).
(Fig. 1). Differential staining ofthese samples revealed
no obvious signs of toxicity as determined by light
microscopy andbytrypanblue dye exclusion (not shown).
In addition, there appeared to be no selective toxicity of
these compounds toward bone marrow cell subpopula-
tions. Thus, thepercentage ofmature andprecursor cells
recovered fromthebone marrowfollowingbenzene treat-
ment remained the same.
Characterization of Bone Marrow Cells by
Flow Cytometry and Antibody Binding
Initially, we characterized subpopulations ofcells iso-
latedfromthebonemarrowofcontrolmice andcompared
them to cellsfrom animalstreatedwithbenzene oracom-
bination of hydroquinone and phenol. Using flow cyto-
metry, we could distinguish between two distinct sub-
populations of bone marrow cells that differed with
respect to size and density as determined by the forward
and right angle light scatterproperties ofthe cells (Fig.
2). These consisted ofalarger, more dense subpopulation
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FIGURE 2. Identification ofsubpopulations ofbone marrowcellsbyflow
cytometry. Thefigure showstheresultsofanalysisofbonemarrow
cellsbasedontheirlaserlight scatterproperties. Cells scatterlight
in the forward angle direction (forward angle light scatter, FALS)
accordingtotheirsizeandintherightangle direction(900light scat-
ter, 900 LS) according to their density orgranularity.
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(population 1)and a smaller, less dense population (popu-
lation 2). Treatment ofmice with benzene or its metabo-
lites had no effect on the light scatter properties of the
bone marrow cells (not shown).
To further characterize these subpopulations, we used
the monoclonal antibody, Mac-1. This antibody binds to
the CR3 receptor on mature mouse macrophages and
granulocytes. By indirect immunofluorescence and flow
cytometry, we foundthat only subpopulation 1 boundthe
Mac-1 antibody (Fig. 3). Sorting and microscopic exami-
nation ofthis subpopulation confirmed that it consisted
predominantly ofmacrophages, monocytes, andgranulo-
cytes (not shown). Benzene had no effect on Mac-1 bind-
ingto the cells, conflrmingthat theproportion ofmacro-
phages and granulocytes in the bone marrow was
unaffected by treatment of the mice (not shown).
Production of Hydrogen Peroxide by Bone
Marrow Phagocytes
To determine if macrophages and granulocytes from
bone marrow ofbenzene-treated miceproduced elevated
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levels of reactive oxygen intermediates, we monitored
hydrogen peroxide production by these cells using
DCFH-DA. In these experiments, a map or gate was
drawn aroundpopulation 1, the Mac-1 positive cells(Figs.
2 and 3.) Hydrogen peroxide production by this subpopu-
lation was then quantified. We found thatbasallevels of
hydrogen peroxide production by Mac-1 positive cells
from control and treated mice were similar (Fig. 4). In
contrast, phagocytes (Mac-1 positive cells) from benzene
treated mice produced 50% more hydrogen peroxide in
response to thephorbol estertumorpromoter, TPA, than
did cells from control animals (Fig. 4).
Similarresultswere observedwith cells obtainedfrom
the hydroquinone-phenol treated mice (not shown). In
separate studies, we also found that the production of
hydrogen peroxide by bone marrow phagocytes in re-
sponse to TPAwas inhibited bypretreatment ofthe cells
for 5 min with 1 ,uM catalase (not shown). These results
demonstrate that bone marrow phagocytes from
benzene-treated mice are activated.
Discussion
Activatedphagocytes are characterizedby alteredmor-
phology, enhanced functional capacity, and release of
reactive mediators. Although it isgenerally assumed that
this results in more rapid destruction offoreign antigens,
recent evidence suggests that the release of reactive
mediators fromphagocytesmay also contribute to tissue
injury (19,20). In the present studies we characterized
macrophages and granulocytes isolated from bone mar-
row of mice treated with benzene, or its metabolites,
hydroquinone and phenol, and determined ifthey were
activated. We found that acute benzene treatment
reduced the total number of cells in the bone marrow.
However, the percentage ofdifferent subpopulations of
cell types in the bone marrow remained the same as de-
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FIGURE 3. Binding ofthe anti-phagocyte monoclonal antibody, Mac-1 to
subpopulations ofbone marrow cells. Bone marrow cells isolatedfrom
control andtreated mice wereincubatedfor30min at40C withMac-1
antibodyfollowed by incubation with FITC-labeled goat antirat IgG.
Binding ofMac-1 antibody to subpopulations ofbone marrow cells,
identified by differences in size and density as shown in Fig. 2, was
then quantified by flow cytometry. The data are presented as log
green fluorescence intensity, which is directly proportional to the
amount ofMac-1 antibodybinding, versusfrequency orcell number.
Anincrease influorescence intensity represents antibodybindingto
the cells.
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FIGURE 4. Stimulation ofhydrogen peroxide production by bone mar-
rowphagocytesfollowingbenzenetreatmentofmice. Bone marrow
cells from control (unshaded curves) or benzene-treated (shaded
curves) mice were incubated with the hydrogen peroxide indicator
dye, DCFH-DA for 15 min and then stimulated with A, control
(HBSS)orB,TPA(170nM)for20min. Thecellswerethen separated
byflow cytometry on the basis ofsize and density as shown in Fig.
2. A gate was set around the Mac-1 positive cells (population 1) and
hydrogen peroxide production by this subpopulation quantified on
thebasisoffluorescence intensity. The dataarepresented asfluores-
cence intensity, which is directlyproportional tohydrogenperoxide
production in these cells, versus frequency or cell number.
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termined morphologically andbyMac-1 binding. This sug-
gested that the cytotoxic effects ofbenzene onbone mar-
row cells were not selective. In addition, although there
were no obvious morphological differences between the
bone marrow cell types as determined by light
microscopy, phagocytes from benzene-treated mice
produced 50% more hydrogen peroxide following stimu-
lationwithTPAthan did cells from control mice andthus,
may be considered activated.
Reactive oxygen intermediates such as superoxide an-
ion and hydrogen peroxide have been implicated as pri-
mary mediators of macrophage-induced cellular injury
and may play arole inbenzene-induced cytotoxicity. Fol-
lowing stimulation, activated phagocytes produce su-
peroxide anion, which can react with water and other
molecules to generate hydroperoxy- and hydroxyl radi-
cals (19,20). These radicals are highly toxic and can ini-
tiate membrane lipid peroxidation reactions and induce
direct damage to cellular macromolecules. Changes in
membrane lipid composition such as those induced by
lipidperoxidation canleadto alterationsin cellmembrane
permeability, disruption of cellular homeostasis, and
eventually to cell death. Thus, the decrease inbone mar-
row cellularity observed followingbenzene exposure may
be mediated, at least in part, by oxygen radicals gener-
ated from activated bone marrow phagocytes.
Bone marrow macrophages activatedby benzene have
also been reported to release elevated levels of
interleukin-1, as well as other cytokines that can stimu-
late proliferation and differentiation ofbonemarrow stem
cells and stromal cell production ofgrowth factors (11).
This canleadto increased proliferation ofsubpopulations
ofstem cells that may contribute to the development of
benzene-induced leukemia.
Based on these results, wepropose amodel ofbenzene-
induced bone marrow toxicity (Fig. 5). According to our
model, phagocytes (macrophages andgranulocytes) inthe
bone marrow become activated following exposure ofthe
animal to benzene and/or its metabolites. Activation may
occur by direct interaction ofthese compounds with the
phagocytes or indirectly by products released from
damaged bone marrow tissue and cells. These activated
phagocytesproduce inflammatory mediators such as su-
peroxide anion andhydrogenperoxide thatmay be cyto-
toxic.
Immune mediators (IM) andcytokines are also released
by activated phagocytes and these may stimulate or in-
hibitgrowthofsubpopulations ofbone marrow stemcells.
Decreased cell proliferation maylead to acute bone mar-
row depression while enhancedcellproliferationmaylead
to leukemia. Thus, accordingto ourmodel, activatedbone
marrowphagocytes may contribute to both the acute and
long-term hematotoxic actions ofbenzene and its metabo-
lites. The data presented in this paper together with
those reported previously by other laboratories (9,11)
support this hypothesis. Based on our model we would
predict thatactivatedphagocytes inthebone marrow can
interact with and directly damage stem cells. Cytotoxic-
ity studies with benzene-activated bone marrow macro-
phages are in progress to explore this possibility.
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FIGURE 5. Model for the potential role ofbone marrow phagocytes in
benzene-induced hematotoxicity. Toxic doses ofbenzene induce ac-
tivation ofbone marrowphagocytes(macrophages andgranulocytes).
These activated phagocytes release reactive oxygen intermediates
(ROI) that are cytotoxic toward stem cells and other stromal cells
resultinginbonemarrow depression. Activated phagocytes canalso
produce elevatedlevels ofimmunemediators(IM)andcytokines in-
cludingIL-1 thataltertheproliferation ofsubpopulationsofbonemar-
row cells and this may be important in leukemogenesis.
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